Condition

Waldenstrom's Macroglobulinaemia (2)

Chronic Hepatitis B (1)

Chronic Lymphocytic Leukemia (1)

Follicular Lymphoma (1)

Indolent B-cell Lymphomas (1)

Lymphoma, Small Lymphocytic (1)

Mantle-Cell Lymphoma (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

The University of Hong Kong (1)

University College, London (1)

Collaborator

Janssen, LP (1)

Intervention

bortezomib (1)

cyclophosphamide (1)

fludarabine (1)

ibrutinib (1)

rituximab (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (2)

Study Type

Interventional (2)

waldenstrom's macroglobulinaemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Waldenstrom's Macroglobulinaemia Trial in United Kingdom (Bortezomib, Cyclophosphamide, Rituximab)

Completed

Waldenstrom's Macroglobulinaemia

Bortezomib
+3 more

Basingstoke, United Kingdom
+29 more

Jun 17, 2021

Chronic Lymphocytic Leukemia, Indolent B-cell Lymphomas, Chronic Hepatitis B Trial in Hong Kong (Ibrutinib)

Unknown status

Chronic Lymphocytic Leukemia
+6 more

Ibrutinib

Hong Kong, Hong Kong

The University of Hong Kong

Apr 11, 2018